relationship between vitamin D treatment with liver involvement severity

The relationship between vitamin D treatment and reduction of liver involvement severity in patients with non-alcoholic liver

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20150802023468N6

Enrollment

100

Registered

2019-10-28

Start date

2019-03-21

Completion date

Unknown

Last updated

2019-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non alcoholic fatty liver disease. Fatty (change of) liver, not elsewhere classified

Interventions

Intervention group: vitamin D 50000 weekly for 4 months.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: vitamin D deficiency patients suffered from non- alcoholic fatty liver disease

Exclusion criteria

Exclusion criteria: alcohol consumption history positive HBS Ag auto immunize hepatitis cancers melitus diabetics thyroid disease chronic kidney disease

Design outcomes

Primary

Measure	Time frame
Grade ultrasound. Timepoint: At the beginning of the study, 4 months. Method of measurement: Sonography.;Vitamin D. Timepoint: At the beginning of the study, 4 months. Method of measurement: blood test.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNiloofar Rabienejad

Tabriz University of Medical Sciences

niloorabi@yahoo.com+98 41 3382 2082

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026